Abstract | BACKGROUND: METHODS: RESULTS: Overall, patients' mean clinic BP was 156.3 ± 22.4/88.9 ± 13.3 mm Hg while taking an average of 4.3 ± 1.1 antihypertensive medications. Prevalence of OSA was 77.3%. Twenty-eight (28.9%) patients had hyperaldosteronism. Urinary sodium level was an independent predictor of severity of OSA only in patients with hyperaldosteronism. CONCLUSIONS: The findings suggest that dietary salt is related to the severity of OSA in patients with resistant hypertension and hyperaldosteronism. The results support dietary salt restriction as a treatment strategy for reduction of OSA severity in these patients.
|
Authors | Eduardo Pimenta, Michael Stowasser, Richard D Gordon, Susan M Harding, Michel Batlouni, Bin Zhang, Suzanne Oparil, David A Calhoun |
Journal | Chest
(Chest)
Vol. 143
Issue 4
Pg. 978-983
(Apr 2013)
ISSN: 1931-3543 [Electronic] United States |
PMID | 23288434
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Sodium, Dietary
- Aldosterone
- Sodium
|
Topics |
- Aldosterone
(urine)
- Blood Pressure
(physiology)
- Comorbidity
- Cross-Sectional Studies
- Female
- Humans
- Hyperaldosteronism
(epidemiology, urine)
- Hypertension
(epidemiology, urine)
- Male
- Middle Aged
- Polysomnography
- Prevalence
- Prospective Studies
- Severity of Illness Index
- Sleep Apnea, Obstructive
(diagnosis, epidemiology, urine)
- Sodium
(urine)
- Sodium, Dietary
(adverse effects)
|